Latest Market Risks News

Mayne Pharma Group has proposed a $7.40 per share acquisition by Cosette Pharmaceuticals, with unanimous board support and a fair and reasonable opinion from an independent expert. Shareholders will vote on the scheme on June 18, 2025.

Kincora Copper Limited reports a strategic pivot to a project generator model, unlocking over A$110 million in partner funding and advancing multiple copper-gold exploration projects across Australia and Mongolia.

Minbos Resources advances its Cabinda Phosphate Project with strong sales interest and a $36 million financing package, positioning itself as a key player in Angola's agricultural transformation.

Bass Oil Limited has announced a $3.1 million rights issue to fund key projects including recommissioning a gas facility in Australia and drilling an oil well in Indonesia, aiming to significantly increase production and cash flow.

Commonwealth Bank of Australia reports a 45 basis point increase in its CET1 capital ratio for Q1 2025, driven by earnings despite rising risk-weighted assets. The bank maintains strong liquidity and leverage ratios above regulatory minimums.

US Masters Residential Property Group reported solid Q1 2025 sales of US$48.07 million and a 5% rise in net operating income, while reducing senior debt by over US$31 million despite ongoing market volatility.

Life360, Inc. reported a strong Q1 2025 with 32% revenue growth to $103.6 million, driven by a 33% increase in subscription revenue and a return to profitability with $4.4 million net income. The company also advanced its strategic positioning through a $4.5 million acquisition and a key partnership.

News Corporation reported a 3% revenue increase to $2.009 billion for Q3 2025, with net income attributable to stockholders tripling to $137 million. The company completed the strategic sale of Foxtel, marking a significant shift in its operations.

VHM Limited has launched a partially underwritten equity placement and share purchase plan to fund the development of its Goschen rare earths and mineral sands project, targeting production by late 2026.

Acrux Limited, partnering with TruPharma, has introduced its Dapsone 7.5% Gel in the US, featuring a unique tube packaging that aims to improve patient convenience and reduce environmental impact.

AVITA Medical reveals a bold expansion plan targeting a $3.5 billion U.S. acute wound care market by 2025, driven by a multi-product portfolio and sustained revenue growth.

Macquarie Group Limited reported a 5% increase in net profit to A$3.715 billion for FY2025, driven by growth in asset management and banking segments alongside a robust capital and liquidity position.